札幌医科大学および株式会社医学生物学研究所との共同研究による新型コロナ関連論文『 SARS-CoV-2 spike protein-derived immunogenic peptides that are promiscuously presented by several HLA-class II molecules and their potential for inducing acquired immunity. 』がHeliyon (IF:4)にアクセプトされました。おめでとうございます！
